Despite record revenue for its latest quarter, the medical device maker's shares sank 8% following its earnings release. But its next stage of growth is coming.
News & Analysis: Abiomed
ABMD earnings call for the period ending March 31, 2021.
I've been waiting to buy these stocks at a better price. Now might just be the time.
There are long-term implications to the coronavirus pandemic that the market is not appreciating.
This medical device company has revenue growth, patents, and a bright outlook.
It's not a vaccine company, a drugmaker, or a diagnostics company.
The company released its latest quarterly report.
ABMD earnings call for the period ending December 31, 2020.
It depends on whether or not the company's decelerating revenue growth is a symptom of larger problems.
ABMD earnings call for the period ending September 30, 2020.